On March 15, 2024, FDA published a white paper titled “Artificial Intelligence & Medical Products: How CBER, CDER, CDRH, and OCP are Working Together” (the AI White Paper) on the use of artificial ...
The paper is intended to promote deeper engagements with stakeholders on potential flexibilities regarding the lot-level ...
As reported in our August 7, 2024, blog item, the U.S. Food and Drug Administration (FDA) announced on August 1, 2024, that it will hold a public meeting on September 25, 2024, on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results